OKUR
OKUR
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
1
$2.59M
Insider Sales
16
$3.43M
Total Volume
$6.02M
17 transactions
Net Activity
$841K
Net selling
Sentiment Rating
Neutral / BalancedCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Moderate distribution: sales represent 57% of total transaction value.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •High accumulation: total purchase value exceeds $1M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Cormorant Asset Management, LP
Former 10% Owner
$3.41M total
Acorn Bioventures, L.P.
10%
$2.59M total
Leverone Jason A.
CFO
$15K total
Saccomano Nicholas A
Pres, CEO
$4K total
Quick Actions
OKUR has an insider buy conviction of 43%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at OKUR (OKUR) engaged in a total of 17 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 16 were sales. The total volume of insider trading reached $6.02M.
The net insider activity for OKUR shows a net selling bias of $841K. This activity represents a 43% buy ratio, suggesting that insiders are currently neutral on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Cormorant Asset Management, LP (Former 10% Owner), who traded 1.81M shares valued at $3.36M on May 15, 2025.
OKUR - OnKure Therapeutics Inc Stock Price and Quote
OnKure Therapeutics Rings the Nasdaq Stock Market Closing Bell
symbol__ Stock Quote Price and Forecast
Insiders' US$16.6m Investments In Red Following OnKure Therapeutics' US$19m Dip In Market Value
OnKure Therapeutics, Inc. (OKUR) stock price, news, quote and history
OKUR Stock Price and Chart — NASDAQ:OKUR
FAQs About OKUR Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for OKUR.